A Novel B7H3 ADC With Strong Bystander Effect Demonstrates Superior Tumor-Inhibition Activity

Time: 2:00 pm
day: Day Two


  • Outlining B7H3 as a target and our novel ADC technique
  • Discussing in vitro characterization and in vivo anti-tumor activity of BAT8009
  • Reviewing Preclinical PK and GLP toxicity study and clinical plan/progress